Corporate | 19 December 2012 13:09
Nanostart AG / Key word(s): Miscellaneous
19.12.2012 13:09
Dissemination of a Corporate News, transmitted by DGAP - a company of
EquityStory AG.
The issuer / publisher is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Frankfurt am Main - December 19, 2012 - Nanostart AG, a nanotechnology
investment company based in Frankfurt, has sold the loans extended to its
holding MagForce, including the corresponding interest receivables, with a
total volume of around EUR 16.1 million to a financial investor. The
receivables were sold at 100% of their principal amount, representing
around EUR 11.8 million, plus interest receivables of around EUR 4.3
million.
The loans were granted to MagForce by Nanostart AG and its subsidiary
VentureTech Equity-Partners GmbH in recent years to finance the holding's
operations. The funds released as a result will be used for new projects
and the expansion of Nanostart's operating activities, particularly in
Asia.
About Nanostart:
Nanostart AG headquartered in the German financial capital of Frankfurt, is
a leading nanotechnology investment company, with portfolio companies
spanning the globe from Silicon Valley to Singapore. The company provides
venture capital financing for nanotechnology companies in various growth
phases with a focus on innovation-driven industries of the future such as
cleantech, life sciences and IT/electronics. As main shareholder of
Nanostart Asia Pacific Ptd Ltd, Nanostart invests as partner of the
Singaporean government.
About MagForce:
MagForce AG is a leading medical technology company in the field of
nanomedicine in oncology. The Company's proprietary, NanoTherm(R) therapy,
enables the targeted treatment of solid tumors through the intratumoral
generation of heat via activation of magnetic nanoparticles. NanoTherm(R),
NanoPlan(R), and NanoActivator(TM) are components of the therapy and have
received EU-wide regulatory approval as medical devices for the treatment
of brain tumors. MagForce, NanoTherm, NanoPlan, and NanoActivator are
trademarks of MagForce AG in select countries. For more information, please
visit www.magforce.com
Disclaimer:
This notice constitutes neither an offer to sell nor a solicitation of
offers to purchase or subscribe to securities. There will be no public
offering of securities of Nanostart AG in conjunction with the existing
listing of its shares in the 'Entry Standard' segment of the regulated
unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This
notice does not constitute a securities prospectus. Neither this notice nor
the information contained within is intended for direct or indirect
distribution within Canada, Australia or Japan.
Media contact:
Nanostart AG
Dr. Hans Joachim Duerr
Head of Corporate Communications
Goethestrasse 26-28
60313 Frankfurt, Germany
phone: +49 (0)69-21 93 96 111
fax: +49 (0)69-21 93 96 150
e-mail: presse@nanostart.de
19.12.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Nanostart AG
Goethestraße 26-28
60313 Frankfurt
Germany
Phone: 069 / 2193 96111
Fax: 069 / 2193 96150
E-mail: presse@nanostart.de
Internet: www.nanostart.de
ISIN: DE000A0B9VV6
WKN: A0B9VV
Listed: Freiverkehr in Berlin, Düsseldorf, München, Stuttgart; Open
Market (Entry Standard) in Frankfurt
End of Announcement DGAP News-Service
---------------------------------------------------------------------------